You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Targeted DNA/RNA Sequencing Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Market Analysis and Insights: Global Targeted DNA/RNA Sequencing Market
The research report studies the Targeted DNA/RNA Sequencing market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Targeted DNA/RNA Sequencing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Targeted DNA/RNA Sequencing Scope and Segment
The global Targeted DNA/RNA Sequencing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Targeted DNA/RNA Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
by Application, this report covers the following segments
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Global Targeted DNA/RNA Sequencing market: regional analysis, the major regions covered in the report are:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Targeted DNA/RNA Sequencing key players in this market include:
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
Genomatix GmbH
Macrogen, Inc.
1 Market Overview of Targeted DNA/RNA Sequencing
1.1 Targeted DNA/RNA Sequencing Market Overview
1.1.1 Targeted DNA/RNA Sequencing Product Scope
1.1.2 Targeted DNA/RNA Sequencing Market Status and Outlook
1.2 Global Targeted DNA/RNA Sequencing Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Targeted DNA/RNA Sequencing Market Size by Region (2016-2027)
1.4 Global Targeted DNA/RNA Sequencing Historic Market Size by Region (2016-2021)
1.5 Global Targeted DNA/RNA Sequencing Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Targeted DNA/RNA Sequencing Market Size (2016-2027)
1.6.1 North America Targeted DNA/RNA Sequencing Market Size (2016-2027)
1.6.2 Europe Targeted DNA/RNA Sequencing Market Size (2016-2027)
1.6.3 Asia-Pacific Targeted DNA/RNA Sequencing Market Size (2016-2027)
1.6.4 Latin America Targeted DNA/RNA Sequencing Market Size (2016-2027)
1.6.5 Middle East & Africa Targeted DNA/RNA Sequencing Market Size (2016-2027)
2 Targeted DNA/RNA Sequencing Market Overview by Type
2.1 Global Targeted DNA/RNA Sequencing Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Targeted DNA/RNA Sequencing Historic Market Size by Type (2016-2021)
2.3 Global Targeted DNA/RNA Sequencing Forecasted Market Size by Type (2022-2027)
2.4 DNA-based Targeted Sequencing
2.5 RNA-based Targeted Sequencing
3 Targeted DNA/RNA Sequencing Market Overview by Application
3.1 Global Targeted DNA/RNA Sequencing Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Targeted DNA/RNA Sequencing Historic Market Size by Application (2016-2021)
3.3 Global Targeted DNA/RNA Sequencing Forecasted Market Size by Application (2022-2027)
3.4 Human Biomedical Research
3.5 Plant & Animal Sciences
3.6 Drug Discovery
3.7 Others
4 Targeted DNA/RNA Sequencing Competition Analysis by Players
4.1 Global Targeted DNA/RNA Sequencing Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted DNA/RNA Sequencing as of 2020)
4.3 Date of Key Players Enter into Targeted DNA/RNA Sequencing Market
4.4 Global Top Players Targeted DNA/RNA Sequencing Headquarters and Area Served
4.5 Key Players Targeted DNA/RNA Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Targeted DNA/RNA Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Illumina Inc.
5.1.1 Illumina Inc. Profile
5.1.2 Illumina Inc. Main Business
5.1.3 Illumina Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.1.4 Illumina Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.1.5 Illumina Inc. Recent Developments
5.2 F. Hoffmann-La Roche Ltd
5.2.1 F. Hoffmann-La Roche Ltd Profile
5.2.2 F. Hoffmann-La Roche Ltd Main Business
5.2.3 F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.2.5 F. Hoffmann-La Roche Ltd Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Profile
5.3.2 Agilent Technologies Main Business
5.3.3 Agilent Technologies Targeted DNA/RNA Sequencing Products, Services and Solutions
5.3.4 Agilent Technologies Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.3.5 GATC Biotech Ag Recent Developments
5.4 GATC Biotech Ag
5.4.1 GATC Biotech Ag Profile
5.4.2 GATC Biotech Ag Main Business
5.4.3 GATC Biotech Ag Targeted DNA/RNA Sequencing Products, Services and Solutions
5.4.4 GATC Biotech Ag Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.4.5 GATC Biotech Ag Recent Developments
5.5 Oxford Nanopore Technologies
5.5.1 Oxford Nanopore Technologies Profile
5.5.2 Oxford Nanopore Technologies Main Business
5.5.3 Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Products, Services and Solutions
5.5.4 Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.5.5 Oxford Nanopore Technologies Recent Developments
5.6 Thermo Fisher Scientific Inc.
5.6.1 Thermo Fisher Scientific Inc. Profile
5.6.2 Thermo Fisher Scientific Inc. Main Business
5.6.3 Thermo Fisher Scientific Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.6.5 Thermo Fisher Scientific Inc. Recent Developments
5.7 DNASTAR Inc.
5.7.1 DNASTAR Inc. Profile
5.7.2 DNASTAR Inc. Main Business
5.7.3 DNASTAR Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.7.4 DNASTAR Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.7.5 DNASTAR Inc. Recent Developments
5.8.1 QIAGEN Profile
5.8.2 QIAGEN Main Business
5.8.3 QIAGEN Targeted DNA/RNA Sequencing Products, Services and Solutions
5.8.4 QIAGEN Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.8.5 QIAGEN Recent Developments
5.9 BGI
5.9.1 BGI Profile
5.9.2 BGI Main Business
5.9.3 BGI Targeted DNA/RNA Sequencing Products, Services and Solutions
5.9.4 BGI Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.9.5 BGI Recent Developments
5.10 Perkin Elmer Inc.
5.10.1 Perkin Elmer Inc. Profile
5.10.2 Perkin Elmer Inc. Main Business
5.10.3 Perkin Elmer Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.10.4 Perkin Elmer Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.10.5 Perkin Elmer Inc. Recent Developments
5.11 Pacific Biosciences of California Inc.
5.11.1 Pacific Biosciences of California Inc. Profile
5.11.2 Pacific Biosciences of California Inc. Main Business
5.11.3 Pacific Biosciences of California Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.11.4 Pacific Biosciences of California Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.11.5 Pacific Biosciences of California Inc. Recent Developments
5.12 Bio-Rad Laboratories Inc.
5.12.1 Bio-Rad Laboratories Inc. Profile
5.12.2 Bio-Rad Laboratories Inc. Main Business
5.12.3 Bio-Rad Laboratories Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.12.4 Bio-Rad Laboratories Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.12.5 Bio-Rad Laboratories Inc. Recent Developments
5.13 Integrated DNA Technologies Inc.
5.13.1 Integrated DNA Technologies Inc. Profile
5.13.2 Integrated DNA Technologies Inc. Main Business
5.13.3 Integrated DNA Technologies Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.13.4 Integrated DNA Technologies Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.13.5 Integrated DNA Technologies Inc. Recent Developments
5.14 RainDance Technologies Inc.
5.14.1 RainDance Technologies Inc. Profile
5.14.2 RainDance Technologies Inc. Main Business
5.14.3 RainDance Technologies Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.14.4 RainDance Technologies Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.14.5 RainDance Technologies Inc. Recent Developments
5.15 PierianDx
5.15.1 PierianDx Profile
5.15.2 PierianDx Main Business
5.15.3 PierianDx Targeted DNA/RNA Sequencing Products, Services and Solutions
5.15.4 PierianDx Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.15.5 PierianDx Recent Developments
5.16 Genomatix GmbH
5.16.1 Genomatix GmbH Profile
5.16.2 Genomatix GmbH Main Business
5.16.3 Genomatix GmbH Targeted DNA/RNA Sequencing Products, Services and Solutions
5.16.4 Genomatix GmbH Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.16.5 Genomatix GmbH Recent Developments
5.17 Macrogen Inc.
5.17.1 Macrogen Inc. Profile
5.17.2 Macrogen Inc. Main Business
5.17.3 Macrogen Inc. Targeted DNA/RNA Sequencing Products, Services and Solutions
5.17.4 Macrogen Inc. Targeted DNA/RNA Sequencing Revenue (US$ Million) & (2016-2021)
5.17.5 Macrogen Inc. Recent Developments
6 North America
6.1 North America Targeted DNA/RNA Sequencing Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Targeted DNA/RNA Sequencing Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Targeted DNA/RNA Sequencing Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Targeted DNA/RNA Sequencing Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Targeted DNA/RNA Sequencing Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Targeted DNA/RNA Sequencing Market Dynamics
11.1 Targeted DNA/RNA Sequencing Industry Trends
11.2 Targeted DNA/RNA Sequencing Market Drivers
11.3 Targeted DNA/RNA Sequencing Market Challenges
11.4 Targeted DNA/RNA Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 125